Virax Biolabs Group Limited Ordinary Shares
A$0.31472
AUD
Last updated on --.
24h volume8.69M
24h highest0.41925 AUD
24h lowest0.29627 AUD
24h Price movement-18.80%
VRAX recent prices
24 Hours
-18.80%-A$0.073089
30 days
+65.01%+A$0.12829
60 days
+75.89%+A$0.16896
90 days
+5.43%+A$0.01677
Key data
Previous close0.38781 AUD
Market cap2.44M AUD
Volume8.69M
P/E ratio--
Dividend yield (TTM)--
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)--
Net income (FY)--
Revenue (FY)--
Last report date--
About Virax Biolabs Group Limited Ordinary Shares
Employees (FY)19.00
Listed onNasdaq
VRAX conversion tables
 |  |
|---|---|
| 0.5 VRAX | 0.15736 AUD |
| 1 VRAX | 0.31472 AUD |
| 5 VRAX | 1.573 AUD |
| 10 VRAX | 3.147 AUD |
| |
|---|---|
| 0.5 AUD | 1.588 VRAX |
| 1 AUD | 3.177 VRAX |
| 5 AUD | 15.88 VRAX |
| 10 AUD | 31.77 VRAX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
VRAX is trading at A$0.31472, -18.80% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VRAX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VRAX is currently trading at A$0.31472, -18.80% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VRAX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VRAX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VRAX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VRAX's historical range and other companies in the sector.
Virax Biolabs Group Limited Ordinary Shares's market cap is currently 2.44M AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume8.69M
24h highest0.41925 AUD
24h lowest0.29627 AUD
24h Price movement-18.80%
Start trade with VRAX Perpetual
Sign up to trade